NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial (vol 391, pg 1174, 2018)

被引：0
|
作者：
Harrison, S. A.
Rinella, M. E.
Abdelmalek, M. F.
机构：
来源：
LANCET | 2018年 / 391卷 / 10126期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E16 / E16
页数：1
相关论文
共 50 条
  • [1] NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Harrison, Stephen A.
    Rinella, Mary E.
    Abdelmalek, Manal F.
    Trotter, James F.
    Paredes, Angelo H.
    Arnold, Hays L.
    Kugelmas, Marcelo
    Bashir, Mustafa R.
    Jaros, Mark J.
    Ling, Lei
    Rossi, Stephen J.
    DePaoli, Alex M.
    Loomba, Rohit
    LANCET, 2018, 391 (10126): : 1174 - 1185
  • [2] Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
    Harrison, Stephen A.
    Bashir, Mustafa R.
    Guy, Cynthia D.
    Zhou, Rong
    Moylan, Cynthia A.
    Frias, Juan P.
    Alkhouri, Naim
    Bansal, Meena B.
    Baum, Seth
    Neuschwander-Tetri, Brent A.
    Taub, Rebecca
    Moussa, Sam E.
    LANCET, 2019, 394 (10213): : 2012 - 2024
  • [3] A double-blind, placebo-controlled trial of pioglitazone in the treatment of non-alcoholic steatohepatitis (NASH)
    Harrison, S
    Belfort, R
    Brown, K
    Darland, C
    Finch, J
    Fincke, C
    Havranek, R
    Hardies, J
    Dwivedi, S
    Berria, R
    Tio, FM
    Schenker, S
    Cusi, K
    GASTROENTEROLOGY, 2005, 128 (04) : A681 - A681
  • [4] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
    Stephen A. Harrison
    Peter J. Ruane
    Bradley L. Freilich
    Guy Neff
    Rashmee Patil
    Cynthia A. Behling
    Chen Hu
    Erica Fong
    Brittany de Temple
    Erik J. Tillman
    Timothy P. Rolph
    Andrew Cheng
    Kitty Yale
    Nature Medicine, 2021, 27 : 1262 - 1271
  • [5] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
    Harrison, Stephen A.
    Ruane, Peter J.
    Freilich, Bradley L.
    Neff, Guy
    Patil, Rashmee
    Behling, Cynthia A.
    Hu, Chen
    Fong, Erica
    de Temple, Brittany
    Tillman, Erik J.
    Rolph, Timothy P.
    Cheng, Andrew
    Yale, Kitty
    NATURE MEDICINE, 2021, 27 (07) : 1262 - +
  • [6] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
    Armstrong, Matthew James
    Gaunt, Piers
    Aithal, Guruprasad P.
    Barton, Darren
    Hull, Diana
    Parker, Richard
    Hazlehurst, Jonathan M.
    Guo, Kathy
    Abouda, George
    Aldersley, Mark A.
    Stocken, Deborah
    Gough, Stephen C.
    Tomlinson, Jeremy W.
    Brown, Rachel M.
    Huebscher, Stefan G.
    Newsome, Philip N.
    LANCET, 2016, 387 (10019): : 679 - 690
  • [7] Probucol in the treatment of non-alcoholic steatohepatitis: A placebo-controlled double-blind study
    Malekzadeh, R
    Merat, S
    Sotoudeh, M
    Sohrabi, MR
    Naseri-Moghadam, S
    Mikaeli, J
    Farahvash, MJ
    Sotoudahmanesh, R
    Ansari, R
    Khatibian, M
    GASTROENTEROLOGY, 2002, 122 (04) : A24 - A24
  • [8] SILYMARIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS: INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Chan, W. K.
    Mustapha, N. R. Nik
    Mahadeva, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S269 - S269
  • [9] Silymarin for the treatment of non-alcoholic steatohepatitis: Interim analysis of a randomized, double-blind, placebo-controlled trial
    Chan, Wah-Kheong
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 324 - 325
  • [10] Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Neff, Guy
    Gunn, Nadege
    Guy, Cynthia D.
    Alkhouri, Naim
    Bashir, Mustafa R.
    Freilich, Bradley
    Kohli, Anita
    Khazanchi, Arun
    Sheikh, Muhammad Y.
    Leibowitz, Mark
    Rinella, Mary E.
    Siddiqui, Mohammad S.
    Kipnes, Mark
    Moussa, Sam E.
    Younes, Ziad H.
    Bansal, Meena
    Baum, Seth J.
    Borg, Brian
    Ruane, Peter J.
    Thuluvath, Paul J.
    Gottwald, Mildred
    Khan, Mujib
    Chen, Charles
    Melchor-Khan, Liza
    Chang, William
    DePaoli, Alex M.
    Ling, Lei
    Lieu, Hsiao D.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (07): : 603 - 616
12345